Truncation of the Deubiquitinating Domain of CYLD in Myelomonocytic Cells Attenuates Inflammatory Responses Conditional Targeting of Cyld in Myeloid Cells
2011

The Role of CYLD in Inflammatory Responses

Sample size: 15 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tsagaratou Ageliki, Kontoyiannis Dimitris L., Mosialos George

Primary Institution: School of Biology, Aristotle University of Thessaloniki

Hypothesis

What is the role of the deubiquitinating activity of CYLD in myelomonocytic cells?

Conclusion

CYLD is a key regulator of monocyte-macrophage activation in response to inflammation and may be a target for treating inflammatory disorders.

Supporting Evidence

  • M-CyldΔ9 mice showed increased resistance to LPS-induced endotoxic shock.
  • Control mice had a survival rate of only 20%, while M-CyldΔ9 mice had a survival rate of 80%.
  • Fewer macrophages were recovered from M-CyldΔ9 mice after thioglycollate injection compared to control mice.

Takeaway

Researchers studied a gene called CYLD in mice to see how it helps immune cells respond to inflammation. They found that without CYLD, these immune cells didn't work as well.

Methodology

Conditional gene targeting was used to create mice with a specific mutation in the Cyld gene, and various inflammatory responses were assessed.

Limitations

The study primarily used mouse models, which may not fully replicate human inflammatory responses.

Participant Demographics

Mice aged 8 weeks were used in the experiments.

Statistical Information

P-Value

0.02

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0016397

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication